D. E. Shaw & Co., Inc. Simulations Plus, Inc. Transaction History
D. E. Shaw & Co., Inc.
- $156 Billion
- Q3 2025
A detailed history of D. E. Shaw & Co., Inc. transactions in Simulations Plus, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 217,810 shares of SLP stock, worth $3.77 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
217,810Holding current value
$3.77 Million% of portfolio
0.0%Shares
19 transactions
Others Institutions Holding SLP
# of Institutions
182Shares Held
17.5MCall Options Held
38.3KPut Options Held
27.7K-
Black Rock Inc. New York, NY2.46MShares$42.7 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.3MShares$22.5 Million0.0% of portfolio
-
Tributary Capital Management, LLC1.14MShares$19.7 Million0.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA974KShares$16.9 Million0.0% of portfolio
-
First Light Asset Management, LLC Edina, MN768KShares$13.3 Million1.39% of portfolio
About Simulations Plus, Inc.
- Ticker SLP
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 20,297,700
- Market Cap $351M
- Description
- Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...